Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter July 12, 2019

Transcutaneous bilirubin to guide phototherapy: authors’ reply

  • Carlos Zozaya EMAIL logo and Abdon Castro
  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

References

1. Ozkan H, Duman N, Tuzun F. Dermal bilirubin kinetics during phototherapy in term neonates. J Perinat Med 2019;47:680–1.10.1515/jpm-2019-0157Search in Google Scholar PubMed

2. Özkan H, Ören H, Duman N, Duman M. Dermal bilirubin kinetics during phototherapy in term neonates. Acta Paediatr Int J Paediatr 2003;92:577–81.10.1111/j.1651-2227.2003.tb02510.xSearch in Google Scholar PubMed

3. Maisels MJ. Neonatal transcutaneous bilirubin measurements: an opportunity to enhance laboratory utilization and improve patient care. Clin Chem 2012;58:1395–6.10.1373/clinchem.2012.183616Search in Google Scholar PubMed

4. Nagar G, Vandermeer B, Campbell S, Kumar M. Effect of phototherapy on the reliability of transcutaneous bilirubin devices in term and near-term infants: a systematic review and meta-analysis. Neonatology 2016;109:203–12.10.1159/000442195Search in Google Scholar PubMed

5. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114:297–316.10.1542/peds.114.1.297Search in Google Scholar PubMed

Received: 2019-06-17
Accepted: 2019-06-18
Published Online: 2019-07-12
Published in Print: 2019-08-27

© 2019 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 30.3.2024 from https://www.degruyter.com/document/doi/10.1515/jpm-2019-0220/html
Scroll to top button